Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomohide Tamura

Showing results (61-70 of 263) with videos related to

Pageof 27
Sort By:
Respiratory Investigation|October 9, 2018
Pemetrexed and carboplatin combination therapy followed by pemetrexed maintenance in Japanese patients with non-squamous non-small cell lung cancer: A subgroup analysis of elderly patientsNaoyuki Nogami, Makoto Nishio, Isamu Okamoto, et al.
Japanese Journal of Clinical Oncology|July 12, 2011
Combination chemotherapy with carboplatin and paclitaxel for advanced thymic cancerMakoto Furugen, Ikuo Sekine, Koji Tsuta, et al.
Internal Medicine (Tokyo, Japan)|January 11, 2019
Primary Synovial Sarcoma of the Mediastinum with Long-term Follow-upHiroaki Kanemura, Naoki Nishimura, Toru Bando, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 2, 2008
Influence of previous chemotherapy on the efficacy of subsequent docetaxel therapy in advanced non-small cell lung cancer patientsYasushi Goto, Ikuo Sekine, Kazuhiko Yamada, et al.
American Journal of Clinical Oncology|October 7, 2003
Retrospective analysis of safety and efficacy of low-dose docetaxel 60 mg/m2 in advanced non-small cell lung cancer patients previously treated with platinum-based chemotherapyYoichi Nakamura, Hideo Kunitoh, Kaoru Kubota, et al.
Japanese Journal of Clinical Oncology|February 16, 2013
Successful EGFR-TKI rechallenge of leptomeningeal carcinomatosis after gefitinib-induced interstitial lung diseaseShinji Nakamichi, Kaoru Kubota, Hidehito Horinouchi, et al.
Lung Cancer (Amsterdam, Netherlands)|April 29, 2019
Corrigendum to "Analysis of central nervous system efficacy in the J-ALEX study of alectinib versus crizotinib in ALK-positive non-small-cell lung cancer" [Lung Cancer 121 (July) (2018) Pages 37-40]Makoto Nishio, Kazuhiko Nakagawa, Tetsuya Mitsudomi, et al.
Advances in Therapy|September 16, 2023
Pooled Analysis of Studies Evaluating Fosnetupitant and Risk Factors for Cisplatin-Induced Nausea and Vomiting During the Extended Overall PhaseNaoki Inui, Yukihiro Toi, Yasuto Yoneshima, et al.
Cancer Science|February 11, 2012
Brain metastases after definitive concurrent chemoradiotherapy in patients with stage III lung adenocarcinoma: carcinoembryonic antigen as a potential predictive factorHidehito Horinouchi, Ikuo Sekine, Minako Sumi, et al.
Japanese Journal of Clinical Oncology|June 4, 2011
Amrubicin monotherapy for patients with previously treated advanced large-cell neuroendocrine carcinoma of the lungHiroshi Yoshida, Ikuo Sekine, Koji Tsuta, et al.
Pageof 27

Showing results (61-70 of 263) with videos related to

Sort By:
Pageof 27
Respiratory Investigation|October 9, 2018
Pemetrexed and carboplatin combination therapy followed by pemetrexed maintenance in Japanese patients with non-squamous non-small cell lung cancer: A subgroup analysis of elderly patientsNaoyuki Nogami, Makoto Nishio, Isamu Okamoto, et al.
Japanese Journal of Clinical Oncology|July 12, 2011
Combination chemotherapy with carboplatin and paclitaxel for advanced thymic cancerMakoto Furugen, Ikuo Sekine, Koji Tsuta, et al.
Internal Medicine (Tokyo, Japan)|January 11, 2019
Primary Synovial Sarcoma of the Mediastinum with Long-term Follow-upHiroaki Kanemura, Naoki Nishimura, Toru Bando, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 2, 2008
Influence of previous chemotherapy on the efficacy of subsequent docetaxel therapy in advanced non-small cell lung cancer patientsYasushi Goto, Ikuo Sekine, Kazuhiko Yamada, et al.
American Journal of Clinical Oncology|October 7, 2003
Retrospective analysis of safety and efficacy of low-dose docetaxel 60 mg/m2 in advanced non-small cell lung cancer patients previously treated with platinum-based chemotherapyYoichi Nakamura, Hideo Kunitoh, Kaoru Kubota, et al.
Japanese Journal of Clinical Oncology|February 16, 2013
Successful EGFR-TKI rechallenge of leptomeningeal carcinomatosis after gefitinib-induced interstitial lung diseaseShinji Nakamichi, Kaoru Kubota, Hidehito Horinouchi, et al.
Lung Cancer (Amsterdam, Netherlands)|April 29, 2019
Corrigendum to "Analysis of central nervous system efficacy in the J-ALEX study of alectinib versus crizotinib in ALK-positive non-small-cell lung cancer" [Lung Cancer 121 (July) (2018) Pages 37-40]Makoto Nishio, Kazuhiko Nakagawa, Tetsuya Mitsudomi, et al.
Advances in Therapy|September 16, 2023
Pooled Analysis of Studies Evaluating Fosnetupitant and Risk Factors for Cisplatin-Induced Nausea and Vomiting During the Extended Overall PhaseNaoki Inui, Yukihiro Toi, Yasuto Yoneshima, et al.
Cancer Science|February 11, 2012
Brain metastases after definitive concurrent chemoradiotherapy in patients with stage III lung adenocarcinoma: carcinoembryonic antigen as a potential predictive factorHidehito Horinouchi, Ikuo Sekine, Minako Sumi, et al.
Japanese Journal of Clinical Oncology|June 4, 2011
Amrubicin monotherapy for patients with previously treated advanced large-cell neuroendocrine carcinoma of the lungHiroshi Yoshida, Ikuo Sekine, Koji Tsuta, et al.
Pageof 27